Riggs Rory B 的 Form 4 申報

Royalty Pharma plc（RPRX），2021/9/30 申報

申報編號: 0001209191-21-058170
申報時間: 2021/9/30
交易日: 2021/9/10-9/29
申報延遲: 20 天遲報
10b5-1 計畫: 表單沒有這欄（2023 年以前）

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 11 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $468.8 萬。交易後 20 天才申報，超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Riggs Rory BCIK 0001016835	董事

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2021/9/28	Class A Ordinary Shares	S賣出處分	−40,000	$36.75^F1	−$1,470,000	639,760	直接
2021/9/29	Class A Ordinary Shares	S賣出處分	−24,648	$36.50^F2	−$899,652	615,112	直接
2021/9/29	Class A Ordinary Shares	J其他取得	+2,334	–^F4	–	617,446	直接
2021/9/29	Class A Ordinary Shares	J其他取得	+5,299	–^F4	–	622,745	直接
2021/9/29	Class A Ordinary Shares	J其他取得	+8,641	–^F4	–	631,386	直接
2021/9/29	Class A Ordinary Shares	S賣出處分	−34,604	$36.31^F7	−$1,256,471.24	899,306	間接
2021/9/29	Class A Ordinary Shares	J其他處分	−109,814	–^F8	–	789,492	間接
2021/9/29	Class A Ordinary Shares	S賣出處分	−22,173	$36.31^F7	−$805,101.63	3,429,085	間接
2021/9/29	Class A Ordinary Shares	J其他處分	−511,727	–^F9	–	2,917,358	間接
2021/9/29	Class A Ordinary Shares	S賣出處分	−7,000	$36.67^F10	−$256,690	2,074,540	間接
2021/9/29	Class A Ordinary Shares	J其他處分	−314,886	–^F11	–	1,759,654	間接

衍生性證券（表 II）

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日	證券	交易	標的股數	單價	金額	交易後持有	持有方式	旗標
2021/9/10	Class A Ordinary Shares	G贈與處分	−76,920	$0.00	$0	534,059	直接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.58 to $36.96 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $36.87 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

表 I 有 1 筆交易的價格引用這則附註。

Pro rata distribution from a limited liability company of which the Reporting Person is a member.

表 I 有 3 筆交易的價格引用這則附註。

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $36.50 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 2 筆交易的價格引用這則附註。

New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.

表 I 有 1 筆交易的價格引用這則附註。

New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.

表 I 有 1 筆交易的價格引用這則附註。

F10

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.62 to $36.75 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F11

New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文（在新分頁開啟）